Logo image of TALS

TALARIS THERAPEUTICS INC (TALS) Stock Analyst Earnings Estimates

NASDAQ:TALS - Nasdaq - US87410C1045 - Common Stock - Currency: USD

2.72  -0.02 (-0.73%)

After market: 2.75 +0.03 (+1.1%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
TALS revenue by date.TALS revenue by date.
N/AN/AN/AN/AN/A
502.30%		N/A
130.83%		N/A
59.34%		N/A
51.81%
EBITDA
YoY % growth
TALS ebitda by date.TALS ebitda by date.
-18M-22.23M
-23.50%		-46.884M
-110.90%		-74.894M
-59.74%		N/A
37.36%		N/A
11.74%		N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
TALS ebit by date.TALS ebit by date.
-18.38M-22.68M
-23.39%		-47.507M
-109.47%		-76.277M
-60.56%		N/A
32.34%		N/A
-42.15%		N/A
-31.06%		N/A
-11.60%		N/A
42.92%		N/A
121.07%		N/A
602.03%		N/A
120.77%
Operating Margin
TALS operating margin by date.TALS operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
TALS eps by date.TALS eps by date.
N/AN/A-2.38-1.79
24.79%		N/A
22.08%		N/A
25.05%		N/A
-55.12%		N/A
10.06%		N/A
44.06%		N/A
121.25%		N/A
570.59%		N/A
83.33%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q3 / 23 Q4 / 23
EPS
Q2Q % growth		-0.15
66.74%		-0.17
60.59%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		N/AN/A
EBIT
Q2Q % growth		-6.63M
66.21%		-6.63M
66.56%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2023
Q2Q % growth		 -0.54
-20.00%		-0.36-0.18-51.26%
Q4 2022
Q2Q % growth		 -0.44
-25.71%		-0.500.0611.96%
Q3 2022
Q2Q % growth		 -0.46
-43.75%		-0.470.011.25%
Q2 2022
Q2Q % growth		 -0.44
-7.32%		-0.470.037.23%
Q1 2022
Q2Q % growth		 -0.45
65.38%		-0.36-0.09-26.05%
Q4 2021
Q2Q % growth		 -0.35 -0.360.011.96%
Q3 2021
Q2Q % growth		 -0.32 -0.30-0.02-5.75%
Q2 2021
Q2Q % growth		 -0.41 -0.27-0.14-54.60%
Q1 2021
Q2Q % growth		 -1.30 -0.27-1.03-380.95%
TALS Yearly EPS VS EstimatesTALS Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 -1 2 -2
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
TALS Yearly Revenue VS EstimatesTALS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 0% 0% 0%
RevenueN/A N/A N/A N/A